Clinical Trials Sponsored by Henit Yanai

Total 108 results

Henit Yanai
Shaare Zedek Medical Center

Unknown

Curcumin Supplementation as an Add on Treatment for Patients With Inflammatory Bowel Diseases Treated With Vedolizumab

Inflammatory Bowel Diseases

Israel
Yantai Yuhuangding Hospital

Recruiting

Study of NK Combined With Chemotherapy for Advanced Solid Tumor (NK)

Solid Tumor

China
Yantai Yuhuangding Hospital

Completed

The Application of Emotion Release Technology in Anxiety Patients Before Daytime Thyroid Surgery

Anxiety | Day Surgery | Preoperative Nursing Care | Emotional Freedom Technique

China
Yantai Yuhuangding Hospital

Completed

Predictive Model for Pain After TACE

Hepatocellular Carcinoma

China
Yantai Yuhuangding Hospital

Recruiting

Clinical Study of Allergic Rhinitis Therapy by Stem Cells

Allergic Rhinitis

China
Yantai Yuhuangding Hospital

Recruiting

Study of DC-CIK Combined With Chemotherapy for Advanced Solid Tumor (DC-CIK)

Solid Tumor

China
Yantai Yuhuangding Hospital

Completed

Application of Iced Normal Saline Combined With Cocktail Perfusion in Total Knee Arthroplasty

Pain, Postoperative | Blood Loss, Postoperative

China
Yantai Yuhuangding Hospital

Recruiting

Early Identification and Prognosis Prediction of Sepsis Through Multiomics (EIPPSM)

Sepsis

China
Yantai Yuhuangding Hospital

Recruiting

Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells

Alcoholic Cirrhosis

China
Yantai Yuhuangding Hospital

Recruiting

Treatment of Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells

Knee Osteoarthritis

China
Yantai Yuhuangding Hospital

Terminated

Mesenchymal Stem Cell Transplantation for Osteoarthritis

Knee Osteoarthritis

China
Yantai YenePharma Co., Ltd.

Unknown

Safety, Tolerability and Pharmacokinetics of Y-2(Edaravone And Borneol) Sublingual Tablet

Intracranial Hemorrhages | Stroke, Acute

United States
YaNi Peng

Completed

Exploration of New Nursing Models for Urological Surgery

Urological Nursing

China
Xijing Hospital
Yantai Medgenn Ltd.

Unknown

Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)

Lung Neoplasms

China
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

Phase Ⅱ and Ⅲ Trial of a SARS-CoV-2 Vaccine LYB001

COVID-19
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

The Phase Ⅱ/Ⅲ Trial of LYB001

COVID-19
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

A Phase Ⅰ Trial to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine LYB001

COVID-19
Juan Carlos M. Andreani MD
Fundación CENIT

Not yet recruiting

Lateral Cord Stimulation as a New Treatment for Refractory Spastic Cerebral Palsy (Andreani1)

Cerebral Palsy | Spasticity

Argentina, Germany
Yantai LNC Biotechnology Singapore PTE. LTD.

Not yet recruiting

The Safety and Dosimetry Study of 177Lu-LNC1003 Injection

Metastatic Castration-resistant Prostate Cancer, mCRPC
Shanghai Mental Health Center
Yantai University

Completed

Assessing Dopamine Transporter Occupancy in the Healthy Adult Brain With Toludivenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)

Major Depressive Disorder

China
Yana Najjar

Recruiting

Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma

Melanoma

United States
Shanghai Mental Health Center
Yantai University

Recruiting

Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)

Major Depressive Disorder

China
Yantai LNC Biotechnology Singapore PTE. LTD.

Recruiting

The Safety and Dosimetry Study of 177Lu-LNC1004 Injection

Solid Tumor, Unspecified, Adult

Singapore
Zhang Yanli

Completed

Short-term Effects of Bowel Preparation on Gut Microbiome in Patients Undergoing Endoscopic Colon Polypectomy

Colon Polyp | Cathartic Colon

China
Yandi Zhu

Recruiting

Study on Symptom Clusters During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution

Ovarian Cancer | Radiotherapy Side Effect | Symptom Cluster

China
Yantai Yuhuangding Hospital
University of Southern California

Recruiting

Prognostic Observation of Posterior Reversible Encephalopathy Syndrome (POPRES)

Posterior Reversible Encephalopathy Syndrome

China
Yantai Yuhuangding Hospital
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Pyrotinib Combined With Trastuzumab,Dalpiciclib and Letrozole for HR+/HER2+ Breast Cancer

Breast Cancer

China
Yana Najjar
Replimune Inc.

Recruiting

RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis

Melanoma

United States
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years

Herpes Zoster

Australia
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Terminated

Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Withdrawn

Immunogenicity and Safety of COVID-19 Vaccine in Population Aged 18 Years and Above

COVID-19

China
Yana Najjar
Bristol-Myers Squibb; Pfizer

Active, not recruiting

Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma

Unresectable Melanoma | Advanced Melanoma

United States
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine （CHO Cell）LYB002V14 in Booster Vaccination

SARS-CoV-2 | COVID-19 Vaccine

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Active, not recruiting

Safety and Immunogenicity of COVID-19 Vaccine in Population Aged 18 Years and Above

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Active, not recruiting

Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above

COVID-19

China
Yana Najjar
Merck Sharp & Dohme LLC

Recruiting

A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma

Advanced Melanoma

United States
Yana Najjar
Merck Sharp & Dohme LLC

Completed

Neoadjuvant Combination Biotherapy With Pembrolizumab and High Dose IFN-alfa2b

Melanoma

United States
Yana Najjar
Merck Sharp & Dohme LLC

Terminated

Dose-seeking Study of Pembrolizumab Plus Vemurafenib and Cobimetinib Advanced Melanoma

Melanoma

United States
Shandong University
The Affiliated Hospital of Qingdao University; Yantai Yuhuangding Hospital

Unknown

Rituximab Combining Bortezomib Versus Rituximab in Management of ITP

Purpura, Thrombocytopenic, Idiopathic | Immune Thrombocytopenia

China
Shenzhen Hornetcorn Bio-technology Company, LTD
Yantai City Hospital for Infectious Diseases

Unknown

DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma

Neoplasms | Digestive System Neoplasms | Hepatocellular Carcinoma

China
Nader Sanai
Barrow Neurological Institute; Ivy Brain Tumor Center

Recruiting

Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG

Glioma | Glioblastoma | High Grade Glioma | Glioma, Malignant

United States
Nader Sanai
BeiGene; Barrow Neurological Institute; Ivy Brain Tumor Center

Recruiting

Study of Pamiparib in Newly Diagnosed and rGBM

Glioblastoma | Glioblastoma Multiforme | Glioblastoma Multiforme, Adult

United States
Guangzhou Patronus Biotech Co., Ltd.
Afﬁliated Hospital of North Sichuan Medical College; Yantai Patronus Biotech...

Active, not recruiting

The Immunogenicity and Safety Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB001

COVID-19 | Vaccine Reaction

China
Nader Sanai
AstraZeneca; Barrow Neurological Institute; Ivy Brain Tumor Center

Recruiting

AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients

Glioma | Glioblastoma | Glioblastoma Multiforme | Glioma, Malignant

United States
Nader Sanai
Novartis; Barrow Neurological Institute; Ivy Brain Tumor Center

Active, not recruiting

Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients

Glioblastoma Multiforme | Meningioma

United States
Guangzhou Patronus Biotech Co., Ltd.
Afﬁliated Hospital of North Sichuan Medical College; Yantai Patronus Biotech...

Active, not recruiting

The Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002

COVID-19

China
Nader Sanai
Barrow Neurological Institute; Ivy Brain Tumor Center; QED Therapeutics

Terminated

Infigratinib in Recurrent High-Grade Glioma Patients

Glioma | Glioblastoma | GBM

United States
Shandong University
Qingdao University; Qianfoshan Hospital; Jinan Central Hospital; The Second Hospital... and other collaborators

Unknown

Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia

Immune Thrombocytopenia

China
Beijing Pins Medical Co., Ltd
Qilu Hospital of Shandong University; Qingdao University; Yantai Yuhuangding... and other collaborators

Unknown

Trial to Assess Vagus Nerve Stimulation Therapy in Children With Lennox-Gastaut Syndrome

Lennox-Gastaut Syndrome

China
Nader Sanai
InSightec; SonALAsense, Inc.; Barrow Neurological Institute; Ivy Brain Tumor Center

Recruiting

Study of Sonodynamic Therapy in Participants With Recurrent High-Grade Glioma

High Grade Glioma

United States

Clinical Trials Sponsored by Henit Yanai

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations